» Articles » PMID: 37772275

Prognostic Value of Combined LMR and CEA Dynamic Monitoring in Postoperative Colorectal Cancer Patients

Overview
Journal J Inflamm Res
Publisher Dove Medical Press
Date 2023 Sep 29
PMID 37772275
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: We aim to investigate the clinical significance of dynamic changes in the lymphocyte-to-monocyte ratio (LMR) and neutrophil-lymphocyte ratio (NLR) in peripheral blood at different time points combined with CEA in the prediction of postoperative-recurrence-in-patients with colorectal cancer (CRC).

Patients And Methods: This study collected 357 patients with stage I-III CRC between 2016 and April 2018. The dynamic changes from preoperative to postoperative LMR (p-LMR-p) and NLR (p-NLR-p) were analyzed using COX regression for multivariate analysis. Logistic regression was used to investigate whether the dynamic changes from post-treatment to pre-end of follow-up LMR (p-LMR-f) and NLR (p-NLR-f) were independent risk factors for CRC recurrence and to construct a predictive model. Internal validation using bootstrapping was performed to validate the discrimination ability of the model. The models' discriminative effect, calibration degree, and clinical utility were assessed.

Results: In both the total cohort and the adjuvant therapy group, the dynamic changes of p-LMR-p (High-High vs Low-Low: p=0.006; HR:2.210, 95% CI: 1.256-3.890) were found to be independent prognostic factors for recurrence-free survival (RFS) in CRC patients. Additionally, logistic regression analysis revealed that N stage, CEA, LMR of pre-end of follow-up (f-LMR), and p-LMR-f were independent risk factors for CRC recurrence. In the total cohort, the p-LMR-f had an area under the curve (AUC) of 0.704, with a sensitivity of 64% and a specificity of 75.3%. By combining p-LMR-f with CEA, a predictive model was constructed, which showed an AUC of 0.913 (0.986-0.913) in the total cohort and an AUC of 0.924 (0.902-0.924) in the adjuvant therapy group during internal validation using bootstrapping.

Conclusion: Dynamic changes in LMR can be used to predict the prognosis of CRC and serve as a biomarker for predicting CRC recurrence. Combined with CEA, it can improve the predictive performance for detecting CRC recurrence.

Citing Articles

A Longitudinal Dynamic Change in LMR Can Be a Biomarker for Recurrence in Fusobacterium Nucleatum-Positive Colorectal Cancer Patients.

Chen S, Chang W, Zhang J, Liu X, Gao T, Qi X J Inflamm Res. 2024; 17:11587-11604.

PMID: 39737097 PMC: 11683201. DOI: 10.2147/JIR.S489432.


Near-infrared light-enhanced colorimetric signal amplification strategy for tumor marker detection based on MoS/CuO/Au nanocomposite.

Xiang J, Zhang B, Yuan Y, Zhao Z, Lin J, Li J Mikrochim Acta. 2024; 191(9):555.

PMID: 39172272 DOI: 10.1007/s00604-024-06630-8.


Prediction of pathological complete response and prognosis in locally advanced rectal cancer.

Xu Y, Tao D, Qin S, Xu X, Yang K, Xing Z World J Gastrointest Oncol. 2024; 16(6):2520-2530.

PMID: 38994151 PMC: 11236239. DOI: 10.4251/wjgo.v16.i6.2520.

References
1.
Hagland H, Lea D, Watson M, Soreide K . Correlation of Blood T-Cells to Intratumoural Density and Location of CD3 and CD8 T-Cells in Colorectal Cancer. Anticancer Res. 2017; 37(2):675-683. DOI: 10.21873/anticanres.11363. View

2.
Waidhauser J, Schuh A, Trepel M, Schmalter A, Rank A . Chemotherapy markedly reduces B cells but not T cells and NK cells in patients with cancer. Cancer Immunol Immunother. 2020; 69(1):147-157. PMC: 11027838. DOI: 10.1007/s00262-019-02449-y. View

3.
Guo G, Wang Y, Zhou Y, Quan Q, Zhang Y, Wang H . Immune cell concentrations among the primary tumor microenvironment in colorectal cancer patients predicted by clinicopathologic characteristics and blood indexes. J Immunother Cancer. 2019; 7(1):179. PMC: 6625045. DOI: 10.1186/s40425-019-0656-3. View

4.
Chan J, Chan D, Diakos C, Engel A, Pavlakis N, Gill A . The Lymphocyte-to-Monocyte Ratio is a Superior Predictor of Overall Survival in Comparison to Established Biomarkers of Resectable Colorectal Cancer. Ann Surg. 2016; 265(3):539-546. PMC: 5300029. DOI: 10.1097/SLA.0000000000001743. View

5.
Yamamoto T, Kawada K, Obama K . Inflammation-Related Biomarkers for the Prediction of Prognosis in Colorectal Cancer Patients. Int J Mol Sci. 2021; 22(15). PMC: 8348168. DOI: 10.3390/ijms22158002. View